- Boston Scientific Corporation
- Abbott
- B. Braun Melsungen AG
- Medtronic
- Stryker
- Biotronik
- C.R. Bard
(Note: The list of the major players will be updated with the latest market scenario and trends)
Recent developments by key players in Stent Delivery Systems Market:
Boston Scientific
In March 2024, the FDA approved Agent, the first drug-coated balloon catheter available in the U.S. for treating coronary in-stent restenosis (ISR). This device utilizes paclitaxel to reopen narrowed vessels and significantly reduces the recurrence of ISR.
Abbott
Launched Ultreon 1.0, an AI-driven coronary imaging platform in Europe in April 2021, enhancing calcium detection and vessel sizing during stent deployment to improve precision.